We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Trupanion
TRUP
$1.18B
| $15.5M | 0.01% |
261,640
-10,609
| -4% | -$712K |
|
|
COOP
1177
DELISTED
Mr. Cooper
COOP
| $15.5M | 0.01% |
382,893
+9,427
| +3% | +$399K |
|
1178
Lyft
LYFT
$6.63B
| $15.5M | 0.01% |
1,177,198
-92,948
| -7% | -$1.43M |
|
1179
Valmont Industries
VMI
$9.53B
| $15.5M | 0.01% |
57,694
-3,164
| -5% | -$836K |
|
1180
Talos Energy
TALO
$2.4B
| $15.5M | 0.01% |
930,582
+413,459
| +80% | +$7.41M |
|
1181
Diamondrock Hospitality Co
DRH
$2.56B
| $15.5M | 0.01% |
2,060,401
+537,863
| +35% | +$4.74M |
|
|
SNV
1182
DELISTED
Synovus
SNV
| $15.4M | 0.01% |
410,908
-12,422
| -3% | -$493K |
|
1183
International Bancshares
IBOC
$4.57B
| $15.4M | 0.01% |
362,174
-24,703
| -6% | -$1.05M |
|
1184
ABM Industries
ABM
$2.84B
| $15.4M | 0.01% |
401,646
-103,258
| -20% | -$4.52M |
|
1185
Bright Horizons
BFAM
$3.86B
| $15.3M | 0.01% |
265,758
-58,106
| -18% | -$4.42M |
|
|
SVC
1186
Service Properties Trust
SVC
$1.07B
| $15.3M | 0.01% |
589,605
+353,822
| +150% | +$11.7M |
|
|
ALE
1187
DELISTED
Allete
ALE
| $15.3M | 0.01% |
305,590
+91,947
| +43% | +$5.47M |
|
|
MASI
1188
DELISTED
Masimo
MASI
| $15.3M | 0.01% |
108,245
-9,564
| -8% | -$1.4M |
|
1189
Interactive Brokers
IBKR
$39.8B
| $15.3M | 0.01% |
955,564
+26,656
| +3% | +$411K |
|
1190
Universal Health Services
UHS
$10.5B
| $15.3M | 0.01% |
173,015
-16,391
| -9% | -$1.69M |
|
1191
Bruker
BRKR
$8.14B
| $15.2M | 0.01% |
287,191
-56,664
| -16% | -$3.39M |
|
|
XRN
1192
Chiron Real Estate Inc
XRN
$477M
| $15.2M | 0.01% |
356,868
+37,008
| +12% | +$2.04M |
|
1193
Acadia Pharmaceuticals
ACAD
$5.03B
| $15.2M | 0.01% |
928,973
-167,229
| -15% | -$2.71M |
|
|
AYX
1194
DELISTED
Alteryx Inc
AYX
| $15.2M | 0.01% |
271,844
+104,714
| +63% | +$6.14M |
|
|
MRC
1195
DELISTED
MRC Global
MRC
| $15.1M | 0.01% |
2,105,565
-1,178,806
| -36% | -$11.6M |
|
|
PRFT
1196
DELISTED
Perficient Inc
PRFT
| $15.1M | 0.01% |
231,997
+988
| +0.4% | +$82.4K |
|
1197
UMB Financial
UMBF
$11.1B
| $15.1M | 0.01% |
178,670
-3,983
| -2% | -$360K |
|
|
DCPH
1198
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $15.1M | 0.01% |
813,649
+669,851
| +466% | +$10.5M |
|
1199
Wingstop
WING
$3.18B
| $15M | 0.01% |
119,827
-2,249
| -2% | -$269K |
|
1200
Ionis Pharmaceuticals
IONS
$9.4B
| $15M | 0.01% |
339,284
-9,402
| -3% | -$396K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.